Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

Developing a diverse portfolio of vaccine candidates for Rift Valley Fever, Chikungunya and Ebola

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

SAC minutes (opens in new window)

Summary of Scientific Advisory Committee meetings

Final periodic report to the EC (opens in new window)

Final periodic report to the EC, containing deliverables

Budget templates (opens in new window)

Budget templates for awardees to complete

List of communication activities conducted, period 2 (opens in new window)

List of main communication activities conducted, period 2

List of communication activities conducted, period 4 (opens in new window)

List of main communication activities conducted, period 4

Project description template (opens in new window)

CEPI's project description template for awardees

List of communication activities conducted, period 3 (opens in new window)

List of main communication activities conducted period 3

3rd periodic report to the EC (opens in new window)

3rd periodic report to the EC containing deliverables

2nd periodic report to the EC (opens in new window)

2nd periodic report to the EC , containing deliverables for given period

Opening of call online (opens in new window)

Validation of the call being opened and made public

Call text (opens in new window)

Call text published on the internet provided to the EC

Publications

Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes (opens in new window)

Author(s): Corey L. Campbell, Trey K. Snell, Susi Bennett, John H. Wyckoff III, Darragh Heaslip, Jordan Flatt, Emma K. Harris, Daniel A. Hartman, Elena Lian, Brian H. Bird, Mark D. Stenglein, Richard A. Bowen, Rebekah C. Kading
Published in: WILEY ONLINE LIBRARY, Issue Volume 69, Issue 5, 2022, Page(s) Pages 2621-2633, ISSN 0000-0000
Publisher: WILEY ONLINE LIBRARY
DOI: 10.1111/tbed.14415

Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera (opens in new window)

Author(s): Pierre Roques, Andrea Fritzer, Nathalie Dereuddre-Bosquet, Nina Wressnigg, Romana Hochreiter, Laetitia Bossevot, Quentin Pascal, Fabienne Guehenneux, Annegret Bitzer, Irena Corbic Ramljak, Roger Le Grand, Urban Lundberg, Andreas Meinke
Published in: JCI Insight, Issue Volume 7, Issue14, 2022, ISSN 2379-3708
Publisher: JCI Insight
DOI: 10.1172/jci.insight.160173

Safety and immunogenicity of four-segmented Rift Valley fever virus in the common marmoset (opens in new window)

Author(s): Wichgers Schreur PJ, Mooij P, Koopman G, Verstrepen BE, Fagrouch Z, Mortier D, van Driel N, Kant J, van de Water S, Bogers WM, Punt C, van Keulen L, Verschoor EJ, Kortekaas J.
Published in: NPJ Vaccines, 2022, ISSN 2059-0105
Publisher: NPJ Vaccines
DOI: 10.1038/s41541-022-00476-y

Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo (opens in new window)

Author(s): Watson-Jones D, Kavunga-Membo H, Grais RF, Ahuka S, Roberts N, Edmunds WJ, Choi EM, Roberts CH, Edwards T, Camacho A, Lees S, Leyssen M, Spiessens B, Luhn K, Douoguih M, Hatchett R, Bausch DG, Muyembe JJ.
Published in: BMJ Open, Issue 2022, 2022, Page(s) 12, ISSN 2044-6055
Publisher: BMJ Publishing Group
DOI: 10.1136/bmjopen-2021-055596

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial (opens in new window)

Author(s): Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl, Andrea Fritzer, Nicole Bézay, Anton Klingler, Karen Lingnau, Martina Schneider, Urban Lundberg, Andreas Meinke, Julian Larcher-Senn, Irena Čorbic-Ramljak, Susanne Eder-Lingelbach, Katrin Dubischar, Wolfgang Bender.
Published in: The Lancet, Issue Volume 20, Issue 10, 2020, ISSN 0140-6736
Publisher: The Lancet Publishing Group
DOI: 10.1016/s1473-3099(20)30238-3

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial (opens in new window)

Author(s): Martina Schneider, Marivic Narciso-Abraham, Sandra Hadl, Robert McMahon, Sebastian Toepfer, Ulrike Fuchs, Romana Hochreiter, Annegret Bitzer, Karin Kosulin, Julian Larcher-Senn, Robert Mader, Katrin Dubischar, Oliver Zoihsl, Juan-Carlos Jaramillo, Susanne Eder-Lingelbach, Vera Buerger, Nina Wressnigg.
Published in: The Lancet, Issue VOLUME 401, ISSUE 10394, 2023, ISSN 0140-6736
Publisher: The Lancet Publishing Group
DOI: 10.1016/s0140-6736(23)00641-4

Searching for OpenAIRE data...

There was an error trying to search data from OpenAIRE

No results available

My booklet 0 0